Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ulcerative colitis
ulcerative colitis
Janssen’s Tremyfa scores success in Phase III ulcerative colitis trial
Clinical Trials Arena
Wed, 05/10/23 - 10:02 am
JNJ
Janssen
clinical trials
Tremyfa
ulcerative colitis
Merck bets big on PRA023 with $10.8bn Prometheus acquisition offer
Clinical Trials Arena
Wed, 05/3/23 - 10:37 pm
Merck
Prometheus Biosciences
PRA023
ulcerative colitis
Takeda tries again with subcutaneous Entyvio
Pharmaphorum
Fri, 04/28/23 - 10:02 am
Takeda
Entyvio
ulcerative colitis
Emerald trial gleams for Morphic
EP Vantage
Wed, 04/26/23 - 10:13 am
Morphic Therapeutic
clinical trials
ulcerative colitis
MORF-057
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
Motley Fool
Fri, 03/31/23 - 10:16 am
Skyrizi
AbbVie
clinical trials
ulcerative colitis
AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
BioSpace
Fri, 03/24/23 - 11:50 am
AbbVie
Skyrizi
ulcerative colitis
lupus
Rinvoq
clinical trials
AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda
Fierce Pharma
Thu, 03/23/23 - 11:39 am
AbbVie
Skyrizi
IBD
ulcerative colitis
clinical trials
Morphic looks to justify “oral Entyvio” excitement
EP Vantage
Wed, 03/15/23 - 10:04 am
Morphic Therapeutics
MORF-057
ulcerative colitis
Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus prospect
Fierce Biotech
Wed, 01/4/23 - 05:22 pm
Roivant Sciences
ulcerative colitis
clinical trials
RVT-3101
Prometheus Biosciences Catapults 176% On Promising Results In UC and Crohn's
Investors Business Daily
Wed, 12/7/22 - 09:40 am
Prometheus Biosciences
clinical trials
ulcerative colitis
Crohn’s disease
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports
PR Newswire
Sun, 12/4/22 - 01:24 pm
Bristol Myers Squibb
AbbVie
Zeposia
Skyrizi
ulcerative colitis
Crohn's Disease
gastroentrologists
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
Thu, 12/1/22 - 10:48 am
JNJ
Janssen
Amgen
legal
ulcerative colitis
patents
Stelara
FDA grants IND clearance for Asieris’ ulcerative colitis drug trial
Clinical Trials Arena
Fri, 11/11/22 - 10:40 am
FDA
Asieris Pharmaceutical
APL-1401
ulcerative colitis
clinical trials
New TREMFYA Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis
Marketscreener
Tue, 10/25/22 - 10:53 am
JNJ
Janssen
clinical trials
ulcerative colitis
Tremfya
Palatin enrols first subject in Phase II ulcerative colitis therapy trial
Clinical Trials Arena
Fri, 10/21/22 - 10:41 am
Palatin Technologies
ulcerative colitis
PL8177
clinical trials
Janssen Touts Positive Mid-Late Stage Data From Two Ulcerative Colitis Trials
BioSpace
Mon, 10/10/22 - 10:52 am
JNJ
Janssen
ulcerative colitis
guselkumab
golimumab
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance
Endpoints
Thu, 07/21/22 - 10:38 am
Pfizer
Gilead Sciences
Big Pharma
ulcerative colitis
Crohn's Disease
drug development
FDA
Why This Promising Drug Will Be Pfizer's Next Blockbuster
Motley Fool
Sun, 07/10/22 - 11:53 pm
Pfizer
etrasimod
ulcerative colitis
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
Motley Fool
Tue, 07/5/22 - 11:05 am
Rinvoq
AbbVie
Europe
ulcerative colitis
AbbVie Redeems Priority Review Voucher for Rinvoq Approval
BioSpace
Thu, 06/23/22 - 07:53 pm
AbbVie
Rinvoq
priority review
priority review vouchers
ulcerative colitis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »